GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Consolidated Construction Consortium Ltd

CCCL Board Appoints S Subramanian as Managing Director/CEO, Re-appoints Two Directors

MANAGEMENT ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 28 Apr 2026, 06:52 PM IST  ·  BSE ID: c0989efc-41c1-4d02-9fdb-af50c00fe83e
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's Board appointed a new Managing Director and re-appointed two existing executives to lead the company for the next five years.
🤖 AI Summary
  • Sri S Subramanian appointed Managing Director/CEO for five years, effective 28 April 2026
  • Sri R Sarabeswar re-appointed Whole-Time Director (Chairman) for five years from 1 July 2026
  • Sri S Sivaramakrishnan re-appointed Whole-Time Director for five years from 1 July 2026
  • All three appointments subject to shareholder approval per Companies Act and SEBI Listing Regulations
🔢 Key Numbers — exact figures from BSE filing, not rounded
S Subramanian MD/CEO appointment term
5 years
R Sarabeswar WTD re-appointment term
5 years
S Sivaramakrishnan WTD re-appointment term
5 years
S Subramanian appointment effective date
28 April 2026
R Sarabeswar and S Sivaramakrishnan effective date
1 July 2026
🏢 How This Affects the Company
⚙️
Operational Impact
Management team structure redefined with new MD/CEO appointment replacing previous leadership configuration. Continuity maintained through re-appointment of two existing Whole-Time Directors under new five-year terms.
⚠️
Risk Impact
Leadership transition introduces near-term execution risk pending shareholder approval. Staggered effective dates (MD from 28 April, other directors from 1 July) may create interim coordination complexity.
👥 What This Means For Shareholders
✅
Action Required
Shareholders must attend AGM to vote on the three management appointment proposals before they become effective.
👤
Who Is Affected
All equity shareholders will vote on management re-appointments. Existing shareholders hold voting rights on Board appointments per Articles of Association.
🔍
Management Signal
Board prioritizes leadership continuity through director re-appointments while introducing new Managing Director to lead operational execution.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
AGM notice and shareholder voting on three management appointment proposals — confirm approval status
Announcement of remuneration and terms for new MD/CEO — watch for detailed compensation disclosure
Regulatory filing post-AGM confirming shareholder approval of management appointments under Regulation 30/41
MEDIUM RISK Leadership transition pending shareholder approval. Staggered effective dates create interim coordination risk. No disclosure of MD/CEO compensation or strategic priorities.
💡 Investor Takeaway
Board approved three management appointments for five-year terms: Sri S Subramanian as MD/CEO (effective 28 April 2026), Sri R Sarabeswar as WTD/Chairman (from 1 July 2026), and Sri S Sivaramakrishnan as WTD (from 1 July 2026). All pending shareholder approval.
⚖️ Strengths & Concerns

✅ Positives

  • Staggered appointment timeline (April for MD, July for WTDs) allows managed transition and oversight continuity.
  • Re-appointment of two existing directors provides operational stability and institutional knowledge retention.

⚠️ Concerns

  • All appointments conditional on shareholder approval — execution risk if shareholders vote against any proposal.
  • No remuneration details disclosed in main filing, limiting investor transparency on compensation structure and incentives.
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.